The California Institute for Regenerative Medicine (CIRM) — a state agency created to advance novel treatments for serious medical conditions — has granted nearly $12 million in funding to support a first-in-human clinical trial that will test a stem cell therapy candidate for Huntington’s disease. The grant was…